Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eijiro Yamada

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Plos One|March 4, 2014
Disruption of Fyn SH3 domain interaction with a proline-rich motif in liver kinase B1 results in activation of AMP-activated protein kinaseEijiro Yamada, Claire C Bastie
JCEM Case Reports|December 20, 2023
Imeglimin Improved Plasma Glucose Levels in Patients With Latent Autoimmune Diabetes of Adults: Report of 2 CasesShuichi Okada, Kazuya Okada, Junichi Okada, et al.
Circulation Reports|January 12, 2026
Transient High-Glucose Exposure and Erk SignalingJunichi Okada, Tsugumichi Saito, Eijiro Yamada, et al.
The Journal of Biological Chemistry|August 26, 2015
Fyn Activation of mTORC1 Stimulates the IRE1α-JNK Pathway, Leading to Cell DeathYichen Wang, Eijiro Yamada, Haihong Zong, et al.
Journal of Health, Population, and Nutrition|November 16, 2019
Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitusJunichi Okada, Eijiro Yamada, Yawara Niijima, et al.
Archives of Physiology and Biochemistry|September 5, 2009
Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?Manu Vatish, Eijiro Yamada, Jeffrey E Pessin, et al.
Endocrine Journal|September 28, 2023
Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetesEijiro Yamada, Yasuyo Nakajima, Kazuhiko Horiguchi, et al.
Current Therapeutic Research, Clinical and Experimental|September 3, 2020
Comparing the efficacy of apple peels and a sodium-glucose cotransporter 2 inhibitor (ipragliflozin) on interstitial glucose levels: A pilot case studyJunichi Okada, Eijiro Yamada, Kazuya Okada, et al.
Endocrinology|July 23, 2015
Tctex1d2 Is a Negative Regulator of GLUT4 Translocation and Glucose UptakeYoko Shimoda, Shuichi Okada, Eijiro Yamada, et al.
Endocrine Journal|November 1, 2021
Pitfalls of intermittent continuous glucose monitoring in patients with steroid diabetesEijiro Yamada, Sho Sekiguchi, Yasuyo Nakajima, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Plos One|March 4, 2014
Disruption of Fyn SH3 domain interaction with a proline-rich motif in liver kinase B1 results in activation of AMP-activated protein kinaseEijiro Yamada, Claire C Bastie
JCEM Case Reports|December 20, 2023
Imeglimin Improved Plasma Glucose Levels in Patients With Latent Autoimmune Diabetes of Adults: Report of 2 CasesShuichi Okada, Kazuya Okada, Junichi Okada, et al.
Circulation Reports|January 12, 2026
Transient High-Glucose Exposure and Erk SignalingJunichi Okada, Tsugumichi Saito, Eijiro Yamada, et al.
The Journal of Biological Chemistry|August 26, 2015
Fyn Activation of mTORC1 Stimulates the IRE1α-JNK Pathway, Leading to Cell DeathYichen Wang, Eijiro Yamada, Haihong Zong, et al.
Journal of Health, Population, and Nutrition|November 16, 2019
Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitusJunichi Okada, Eijiro Yamada, Yawara Niijima, et al.
Archives of Physiology and Biochemistry|September 5, 2009
Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?Manu Vatish, Eijiro Yamada, Jeffrey E Pessin, et al.
Endocrine Journal|September 28, 2023
Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetesEijiro Yamada, Yasuyo Nakajima, Kazuhiko Horiguchi, et al.
Current Therapeutic Research, Clinical and Experimental|September 3, 2020
Comparing the efficacy of apple peels and a sodium-glucose cotransporter 2 inhibitor (ipragliflozin) on interstitial glucose levels: A pilot case studyJunichi Okada, Eijiro Yamada, Kazuya Okada, et al.
Endocrinology|July 23, 2015
Tctex1d2 Is a Negative Regulator of GLUT4 Translocation and Glucose UptakeYoko Shimoda, Shuichi Okada, Eijiro Yamada, et al.
Endocrine Journal|November 1, 2021
Pitfalls of intermittent continuous glucose monitoring in patients with steroid diabetesEijiro Yamada, Sho Sekiguchi, Yasuyo Nakajima, et al.
Pageof 9